Bienaime Jean Jacques: insider trades
Chief executive, Director at 6 companies we cover. 28 open-market purchases and 48 sales not made under a pre-set plan, reported from March 1, 2010 to August 19, 2026.
Would copying Bienaime Jean Jacques’s purchases have beaten the S&P 500?
Too few purchases to judge. Only 13 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on March 2, 2010 into $3,622 by November 2, 2026, −5.9% a year. The copy held shares only 35% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $22,636, +5.0% a year (the S&P 500 held throughout made $90,567, +14.2% a year). Beta against the index was 0.45. Twelve months after each report, the average purchase was −5.6% against the S&P 500 (median −53.0%), and 31% beat it. Measured from the trade date, the insider’s own timing, the average was −5.8%. After their sales, the shares moved +11.5% against the index over 12 months on average (a negative figure means selling was the right call); 32% trailed it.
- Return a year, copying
- −5.9%
- S&P 500, same days invested
- +5.0% (held throughout +14.2%)
- Time in shares
- 35%
- Sharpe ratio (S&P 500)
- 0.08 (0.77)
- Biggest drop (S&P 500)
- −96% (−34%)
- Market sensitivity (beta)
- 0.45
- Purchases copied
- 24
Trade by trade
| Measured | Trades counted | Average vs S&P 500 | Median | Went the right way | Years | t-statistic | p-value | Evidence |
|---|---|---|---|---|---|---|---|---|
| Purchases, 3 months after the report | 23 | +3.2% | −0.6% | 48% | 7 | 1.00 | 0.36 | No reliable evidence |
| Purchases, 6 months after the report | 16 | +2.6% | −14.2% | 44% | 7 | 0.71 | 0.51 | No reliable evidence |
| Purchases, 12 months after the report | 13 | −5.6% | −53.0% | 31% | 6 | −0.19 | 0.86 | No reliable evidence |
| Purchases, 12 months after the trade | 13 | −5.8% | −48.2% | 39% | 6 | −0.22 | 0.84 | No reliable evidence |
| Sales, 3 months after the report | 48 | +2.4% | +3.9% | 44% | 13 | 0.26 | 0.80 | No reliable evidence |
| Sales, 12 months after the report | 47 | +11.5% | +18.6% | 32% | 12 | −0.19 | 0.85 | No reliable evidence |
| Sales, 12 months after the trade | 47 | +10.9% | +18.3% | 34% | 12 | −0.22 | 0.83 | No reliable evidence |
Companies traded
| Company | Title on the latest filing | Purchases | Sales | First report | Latest report |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc BMRN | Chief Executive Officer | 1 | 45 | March 1, 2010 | March 7, 2024 |
| Immunome Inc. IMNM | — | 8 | 1 | May 22, 2024 | June 9, 2026 |
| Incyte INCY | — | 6 | 2 | April 11, 2017 | November 12, 2020 |
| Keros Therapeutics, Inc. KROS | — | 6 | 0 | March 11, 2026 | August 19, 2026 |
| Immunic, Inc. IMUX | — | 4 | 0 | October 9, 2014 | September 14, 2017 |
| Ascendis Pharma A/s ASND | — | 3 | 0 | May 27, 2026 | August 18, 2026 |
Trades and what followed
| Reported | Traded | Company | Trade | Value | 3 months after report | 12 months after report | 12 months after trade |
|---|---|---|---|---|---|---|---|
| August 19, 2026 | August 17, 2026 | KROS | Purchase | $10,270 | not yet | not yet | not yet |
| August 18, 2026 | August 14, 2026 | ASND | Purchase | $492,654 | not yet | not yet | not yet |
| July 17, 2026 | July 15, 2026 | KROS | Purchase | $10,610 | −2.6% | not yet | not yet |
| June 17, 2026 | June 15, 2026 | KROS | Purchase | $10,190 | +2.8% | not yet | not yet |
| June 9, 2026 | June 5, 2026 | IMNM | Sale | $203,820 | +32.8% | not yet | not yet |
| June 9, 2026 | June 5, 2026 | IMNM | Purchase | $204,260 | +32.8% | not yet | not yet |
| June 1, 2026 | May 29, 2026 | ASND | Purchase | $111,562 | +19.6% | not yet | not yet |
| May 27, 2026 | May 26, 2026 | ASND | Purchase | $95,122 | +2.6% | not yet | not yet |
| May 19, 2026 | May 15, 2026 | KROS | Purchase | $10,580 | −3.4% | not yet | not yet |
| May 19, 2026 | May 15, 2026 | IMNM | Purchase | $103,500 | +27.3% | not yet | not yet |
| April 17, 2026 | April 15, 2026 | KROS | Purchase | $11,700 | −15.2% | not yet | not yet |
| March 12, 2026 | March 10, 2026 | IMNM | Purchase | $43,670 | −22.0% | not yet | not yet |
| March 11, 2026 | March 9, 2026 | KROS | Purchase | $22,420 | −19.6% | not yet | not yet |
| June 3, 2025 | June 3, 2025 | IMNM | Purchase | $46,900 | −0.6% | +80.8% | +84.1% |
| March 26, 2025 | March 25, 2025 | IMNM | Purchase | $60,684 | +11.7% | +152.4% | +180.3% |
| March 25, 2025 | March 24, 2025 | IMNM | Purchase | $57,470 | +16.0% | +163.8% | +133.4% |
| August 19, 2024 | August 16, 2024 | IMNM | Purchase | $97,580 | −43.6% | −49.2% | −45.8% |
| May 22, 2024 | May 21, 2024 | IMNM | Purchase | $27,140 | +0.5% | −53.0% | −48.2% |
| March 7, 2024 | March 5, 2024 | BMRN | Sale | $172,220 | −10.8% | −28.5% | −31.0% |
| February 29, 2024 | February 27, 2024 | BMRN | Sale | $90,350 | −17.0% | −33.5% | −40.2% |
| August 9, 2023 | August 7, 2023 | BMRN | Sale | $882,140 | −4.3% | −23.3% | −18.4% |
| December 15, 2022 | December 13, 2022 | BMRN | Sale | $106,890 | −19.7% | −36.9% | −28.1% |
| December 6, 2022 | December 2, 2022 | BMRN | Sale | $155,967 | −11.3% | −29.3% | −25.3% |
| November 1, 2022 | October 31, 2022 | BMRN | Sale | $129,825 | +22.8% | −23.2% | −14.2% |
| December 2, 2021 | December 1, 2021 | BMRN | Sale | $130,830 | −3.3% | +35.3% | +30.1% |
| November 12, 2020 | November 10, 2020 | INCY | Sale | $66,234 | −8.5% | −53.4% | −54.1% |
| August 5, 2019 | August 1, 2019 | INCY | Sale | $146,654 | −5.1% | +0.4% | +3.4% |
| November 9, 2018 | November 8, 2018 | INCY | Purchase | $68,765 | +31.5% | +23.4% | +11.5% |
| September 14, 2017 | September 13, 2017 | IMUX | Purchase | $40,000 | not yet | not yet | not yet |
| June 15, 2017 | June 13, 2017 | IMUX | Purchase | $48,000 | not yet | not yet | not yet |
| June 2, 2017 | May 31, 2017 | INCY | Purchase | $65,900 | +9.2% | −59.7% | −61.6% |
| May 17, 2017 | May 15, 2017 | INCY | Purchase | $57,500 | −8.7% | −64.1% | −57.7% |
| May 2, 2017 | April 28, 2017 | INCY | Purchase | $62,130 | −2.2% | −61.6% | −63.4% |
| April 17, 2017 | April 13, 2017 | INCY | Purchase | $139,660 | −1.6% | −62.2% | −67.2% |
| April 11, 2017 | April 7, 2017 | INCY | Purchase | $139,480 | −8.5% | −64.7% | −66.3% |
| September 11, 2015 | September 9, 2015 | IMUX | Purchase | $43,100 | not yet | not yet | not yet |
| July 9, 2015 | July 7, 2015 | BMRN | Sale | $208,605 | −26.4% | −42.6% | −45.2% |
| March 11, 2015 | March 9, 2015 | BMRN | Sale | $2,362,553 | +3.8% | −23.6% | −21.6% |
| March 5, 2015 | March 5, 2015 | BMRN | Sale | $1,137,000 | +7.3% | −21.1% | −20.8% |
| November 14, 2014 | November 12, 2014 | BMRN | Sale | $81,510 | +22.1% | +26.6% | +20.4% |
| November 12, 2014 | November 10, 2014 | BMRN | Sale | $348,000 | +12.0% | +21.0% | +23.9% |
| November 5, 2014 | November 3, 2014 | BMRN | Sale | $255,990 | +10.6% | +31.3% | +29.6% |
| October 9, 2014 | October 8, 2014 | IMUX | Purchase | $75,005 | +54.5% | −74.1% | −75.5% |
| June 5, 2014 | June 3, 2014 | BMRN | Sale | $122,400 | +5.6% | +91.9% | +88.9% |
| August 19, 2013 | August 15, 2013 | BMRN | Sale | $64,360 | −4.1% | −11.8% | −14.6% |
| May 15, 2013 | May 14, 2013 | BMRN | Sale | $1,773,550 | −2.2% | −26.7% | −33.6% |
| May 15, 2013 | May 14, 2013 | BMRN | Sale | $1,052,550 | −2.2% | −26.7% | −33.6% |
| May 2, 2013 | April 30, 2013 | BMRN | Sale | $194,980 | −9.9% | −29.0% | −31.5% |
| February 28, 2013 | February 27, 2013 | BMRN | Sale | $84,690 | −2.7% | +9.7% | +22.8% |
| December 6, 2012 | December 4, 2012 | BMRN | Sale | $239,700 | +22.1% | +18.9% | +15.6% |
| November 19, 2012 | November 16, 2012 | BMRN | Sale | $384,400 | +4.0% | +9.3% | +5.2% |
| November 15, 2012 | November 14, 2012 | BMRN | Sale | $194,000 | +3.4% | +5.2% | −0.3% |
| November 9, 2012 | November 7, 2012 | BMRN | Sale | $333,300 | +3.2% | −2.0% | −0.4% |
| May 15, 2012 | May 11, 2012 | BMRN | Sale | $1,541,615 | −6.1% | +33.9% | +53.2% |
| March 13, 2012 | March 9, 2012 | BMRN | Sale | $516,900 | +11.0% | +66.8% | +63.0% |
| March 9, 2012 | March 8, 2012 | BMRN | Sale | $35,000 | +8.5% | +66.3% | +63.1% |
| March 1, 2012 | February 29, 2012 | BMRN | Sale | $36,260 | +6.7% | +58.1% | +54.8% |
| February 28, 2012 | February 24, 2012 | BMRN | Sale | $178,220 | +10.5% | +54.8% | +47.9% |
| February 24, 2012 | February 23, 2012 | BMRN | Sale | $176,550 | +9.9% | +46.9% | +46.4% |
| August 31, 2011 | August 30, 2011 | BMRN | Sale | $58,020 | +17.4% | +10.0% | +9.3% |
| August 22, 2011 | August 19, 2011 | BMRN | Sale | $53,500 | +8.7% | +11.5% | +9.8% |
| August 16, 2011 | August 12, 2011 | BMRN | Sale | $81,300 | +7.7% | +15.7% | +20.5% |
| August 4, 2011 | August 2, 2011 | BMRN | Sale | $242,120 | +19.2% | +24.4% | +18.3% |
| June 8, 2011 | June 6, 2011 | BMRN | Sale | $54,780 | +18.2% | +29.3% | +32.4% |
| May 26, 2011 | May 25, 2011 | BMRN | Sale | $26,940 | +11.6% | +37.4% | +40.6% |
| May 12, 2011 | May 10, 2011 | BMRN | Sale | $10,348 | +13.2% | +42.4% | +38.9% |
| May 5, 2011 | May 3, 2011 | BMRN | Sale | $204,810 | +12.9% | +39.7% | +31.1% |
| December 13, 2010 | December 13, 2010 | BMRN | Sale | $27,430 | −14.1% | +18.6% | +20.1% |
| December 7, 2010 | December 6, 2010 | BMRN | Sale | $27,170 | −14.9% | +17.6% | +18.5% |
| November 23, 2010 | November 23, 2010 | BMRN | Sale | $27,020 | −21.4% | +18.9% | +18.7% |
| November 22, 2010 | November 18, 2010 | BMRN | Sale | $25,990 | −19.2% | +18.7% | +13.9% |
| November 9, 2010 | November 8, 2010 | BMRN | Sale | $51,560 | −5.3% | +19.1% | +21.3% |
| November 4, 2010 | November 2, 2010 | BMRN | Sale | $191,595 | −7.2% | +24.8% | +23.9% |
| September 9, 2010 | September 8, 2010 | BMRN | Sale | $22,220 | +7.7% | +22.1% | +18.0% |
| August 31, 2010 | August 30, 2010 | BMRN | Sale | $62,130 | +17.5% | +26.4% | +23.5% |
| March 1, 2010 | February 26, 2010 | BMRN | Purchase | $16,064 | −5.8% | −4.3% | +1.1% |